Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SRNE | US
-0.00
-18.18%
Healthcare
Biotechnology
30/06/2023
24/04/2026
0.00
0.00
0.00
0.00
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
533.6%1 month
484.1%3 months
689.7%6 months
591.5%-
1.18
4.01
-1.01
0.45
-0.25
2.00
-0.07
-341.59M
569.66K
569.66K
-
-510.93
-
31.10
-378.92
4.96
11.96
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.00
Range1M
0.00
Range3M
0.01
Rel. volume
0.10
Price X volume
85.31
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Arsanis Inc | ASNS | Biotechnology | 0.0948 | 570.51K | -3.27% | n/a | 252.35% |
| Iterum Therapeutics plc | ITRM | Biotechnology | 0.0191 | 433.68K | 56.56% | n/a | -198.11% |
| IO Biotech Inc. Common Stock | IOBT | Biotechnology | 0.0062 | 408.46K | 6.90% | n/a | 2.23% |
| Lipella Pharmaceuticals Inc. Common Stock | LIPO | Biotechnology | 0.0302 | 244.76K | n/a | 5.50% | |
| Hepion Pharmaceuticals Inc | HEPA | Biotechnology | 0.04 | 231.97K | 4.71% | n/a | 4.33% |
| Innovation Pharmaceuticals Inc | IPIX | Biotechnology | 0.0003 | 155.50K | -70.00% | n/a | 20.48% |
| Windtree Therapeutics Inc | WINT | Biotechnology | 0.0224 | 82.42K | 1.82% | n/a | 36.99% |
| Syros Pharmaceuticals Inc | SYRS | Biotechnology | 0.0002 | 5.36K | -33.33% | n/a | -954.99% |
| Calithera Biosciences Inc | CALA | Biotechnology | 0.0003 | 1.46K | 200.00% | n/a | 8.17% |
| XOMAP | XOMAP | Biotechnology | 26.125 | 0 | 26.27 | 121.93% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0055 | 507.18K | -37.50% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.25 | 0.53 | Cheaper |
| Ent. to Revenue | 2.00 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.01 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 689.68 | 72.80 | Riskier |
| Debt to Equity | -1.01 | -1.23 | Cheaper |
| Debt to Assets | 0.45 | 0.25 | Expensive |
| Market Cap | 569.66K | 3.66B | Emerging |